|
TABLE OF CONTENTS 1 INTRODUCTION 1.1 OBJECTIVES OF THE STUDY 1.2 MARKET DEFINITION 1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 GEOGRAPHIC SCOPE
1.3.3 YEARS CONSIDERED FOR THE STUDY 1.4 CURRENCY 1.5 LIMITATIONS 1.6 STAKEHOLDERS 2 RESEARCH METHODOLOGY 2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
2.1.2.3 Breakdown of Primaries 2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.2 TOP-DOWN APPROACH 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 2.4 RESEARCH ASSUMPTIONS
2.4.1 ASSUMPTIONS 3 EXECUTIVE SUMMARY 3.1 INTRODUCTION 3.2 HISTORY, EVOLUTION, AND CURRENT SCENARIO 3.3 FUTURE OUTLOOK 3.4 CONCLUSION 4 PREMIUM INSIGHTS 4.1 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, 2014–2019 4.2 GLOBAL TRANSPLANT DIAGNOSTICS TECHNOLOGY MARKET, BY REGION (2014–2019) 4.3 TRANSPLANT DIAGNOSTIC PRODUCTS AND SERVICES MARKET, BY REGION (2014) 4.4 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY END USER (2014–2019) 4.5 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION (2014–2019) 5 MARKET OVERVIEW 5.1 INTRODUCTION 5.2 MARKET SEGMENTATION
5.2.1 TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY
5.2.2 TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT
5.2.3 TRANSPLANT DIAGNOSTICS MARKET, BY END USER
5.2.4 TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 5.3 MARKET DYNAMICS
5.3.1 DRIVERS
5.3.1.1 Rising number of solid organ, soft tissue, and stem cell transplantation procedures
5.3.1.2 Technological advancements in HLA typing
5.3.1.3 Growing geriatric population
5.3.2 RESTRAINTS
5.3.2.1 High cost of PCR and NGS instruments
5.3.2.2 Huge gap between number of organs donated and required annually
5.3.2.3 Limited medical reimbursements available for transplantation procedures
5.3.3 OPPORTUNITIES
5.3.3.1 Growing market penetration in emerging countries
5.3.3.2 Technological shift from serological assays to genome-based HLA profiling 6 INDUSTRY TRENDS 6.1 INTRODUCTION 6.2 VALUE CHAIN ANALYSIS 6.3 PORTER’S FIVE FORCES ANALYSIS
6.3.1 THREAT FROM NEW ENTRANTS
6.3.2 THREAT FROM SUBSTITUTES
6.3.3 BARGAINING POWER OF SUPPLIERS
6.3.4 BARGAINING POWER OF BUYERS
6.3.5 INTENSITY OF COMPETITIVE RIVALRY 7 TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY 7.1 INTRODUCTION 7.2 MOLECULAR ASSAYS
7.2.1 POLYMERASE CHAIN REACTION (PCR)-BASED
7.2.1.1 Sequence-specific Primer PCR (SSP-PCR)
7.2.1.2 Sequence-specific oligonucleotide PCR (SSO-PCR)
7.2.2 SEQUENCING-BASED ASSAYS
7.2.2.1 Sanger sequencing
7.2.2.2 Next-generation sequencing (NGS) 7.3 NON-MOLECULAR ASSAYS
7.3.1 SEROLOGICAL ASSAYS
7.3.2 MIXED LYMPHOCYTE CULTURE (MLC) ASSAYS 8 TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 8.1 INTRODUCTION 8.2 REAGENTS AND CONSUMABLES 8.3 INSTRUMENTS 8.4 SOFTWARE AND SERVICES 9 TRANSPLANT DIAGNOSTICS MARKET, BY END USER 9.1 INTRODUCTION 9.2 HOSPITALS AND TRANSPLANT CENTERS 9.3 COMMERCIAL SERVICE PROVIDERS 9.4 RESEARCH LABORATORIES AND ACADEMIC INSTITUTES 10 TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 10.1 INTRODUCTION 10.2 DIAGNOSTIC APPLICATIONS 10.3 RESEARCH APPLICATIONS 11 TRANSPLANT DIAGNOSTICS MARKET, BY REGION 11.1 INTRODUCTION 11.2 NORTH AMERICA
11.2.1 U.S.
11.2.2 CANADA 11.3 EUROPE
11.3.1 GERMANY
11.3.2 U.K.
11.3.3 FRANCE
11.3.4 REST OF EUROPE 11.4 ASIA-PACIFIC
11.4.1 JAPAN
11.4.2 CHINA
11.4.3 INDIA
11.4.4 REST OF ASIA-PACIFIC 11.5 REST OF THE WORLD 12 COMPETITIVE LANDSCAPE 12.1 OVERVIEW 12.2 MARKET SHARE ANALYSIS, BY KEY PLAYER, 2013 12.3 COMPETITIVE SCENARIO 12.4 RECENT DEVELOPMENTS
12.4.1 MERGERS AND ACQUISITIONS
12.4.2 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
12.4.3 NEW PRODUCT LAUNCHES AND PRODUCT ENHANCEMENTS
12.4.4 GEOGRAPHICAL EXPANSION
12.4.5 OTHER DEVELOPMENTS 13 COMPANY PROFILES
(Overview, Financials, Products & Services, Strategy, & Developments)* 13.1 INTRODUCTION 13.2 THERMO FISHER SCIENTIFIC, INC. 13.3 IMMUCOR, INC. 13.4 OLERUP SSP AB 13.5 QIAGEN N.V. 13.6 BIO-RAD LABORATORIES, INC. 13.7 ABBOTT LABORATORIES, INC. 13.8 ILLUMINA, INC. 13.9 LINKAGE BIOSCIENCES, INC. 13.10 FUJIREBIO EUROPE N.V. *Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies. 14 APPENDIX 14.1 INSIGHTS OF INDUSTRY EXPERTS 14.2 DISCUSSION GUIDE 14.3 COMPANY DEVELOPMENTS
14.3.1 THERMO FISHER SCIENTIFIC 14.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 14.5 AVAILABLE CUSTOMIZATIONS 14.6 RELATED REPORTS
LIST OF TABLES
TABLE 1 GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2012–2019 ($MILLION)
TABLE 2 GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE FOR MOLECULAR ASSAYS, BY TYPE, 2012–2019 ($MILLION)
TABLE 3 TRANSPLANT DIAGNOSTICS TECHNOLOGY MARKET SIZE FOR MOLECULAR ASSAYS, BY REGION, 2012–2019 ($MILLION)
TABLE 4 GLOBAL TRANSPLANT DIAGNOSTICS TECHNOLOGY MARKET SIZE FOR PCR-BASED MOLECULAR ASSAYS, BY TYPE, 2012–2019 ($MILLION)
TABLE 5 TRANSPLANT DIAGNOSTICS TECHNOLOGY MARKET SIZE FOR SSP-PCR-BASED MOLECULAR ASSAYS, BY REGION, 2012–2019 ($MILLION)
TABLE 6 TRANSPLANT DIAGNOSTICS TECHNOLOGY MARKET SIZE FOR SSO-PCR-BASED MOLECULAR ASSAYS, BY REGION, 2012–2019 ($MILLION)
TABLE 7 GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE FOR SEQUENCING-BASED MOLECULAR ASSAYS, BY TYPE, 2012–2019 ($MILLION)
TABLE 8 TRANSPLANT DIAGNOSTICS TECHNOLOGY MARKET SIZE FOR SANGER SEQUENCING-BASED MOLECULAR ASSAYS, BY REGION, 2012–2019 ($MILLION)
TABLE 9 TRANSPLANT DIAGNOSTICS TECHNOLOGY MARKET SIZE FOR NGS-BASED MOLECULAR ASSAYS, BY REGION, 2012–2019 ($MILLION)
TABLE 10 GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE FOR NON-MOLECULAR ASSAYS, BY TYPE, 2012–2019 ($MILLION)
TABLE 11 TRANSPLANT DIAGNOSTICS TECHNOLOGY MARKET SIZE FOR NON-MOLECULAR ASSAYS, BY REGION, 2012–2019 ($MILLION)
TABLE 12 TRANSPLANT DIAGNOSTICS TECHNOLOGY MARKET SIZE FOR SEROLOGICAL ASSAY-BASED NON-MOLECULAR ASSAYS, BY REGION, 2012–2019 ($MILLION)
TABLE 13 TRANSPLANT DIAGNOSTICS TECHNOLOGY MARKET SIZE FOR MLC ASSAY-BASED NON-MOLECULAR ASSAYS, BY REGION, 2012–2019 ($MILLION)
TABLE 14 GLOBAL TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PRODUCTS AND SERVICES, 2012-2019 ($MILLION)
TABLE 15 TRANSPLANT DIAGNOSTICS REAGENTS AND CONSUMABLES MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
TABLE 16 TRANSPLANT DIAGNOSTICS INSTRUMENTS MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
TABLE 17 TRANSPLANT DIAGNOSTICS SOFTWARE AND SERVICES MARKET SIZE, BY REGION, 2012-2019 ($MILLION)
TABLE 18 TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2012–2019 ($MILLION)
TABLE 19 TRANSPLANT DIAGNOSTICS MARKET SIZE FOR HOSPITALS AND TRANSPLANT CENTERS, BY REGION, 2012–2019 ($MILLION)
TABLE 20 TRANSPLANT DIAGNOSTICS MARKET SIZE FOR COMMERCIAL SERVICE PROVIDERS, BY REGION, 2012–2019 ($MILLION)
TABLE 21 TRANSPLANT DIAGNOSTICS MARKET SIZE FOR RESEARCH LABORATORIES AND ACADEMIC INSTITUTES, BY REGION, 2012–2019 ($MILLION)
TABLE 22 TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2012–2019 ($MILLION)
TABLE 23 TRANSPLANT DIAGNOSTICS MARKET SIZE FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2012–2019 ($MILLION)
TABLE 24 TRANSPLANT DIAGNOSTICS MARKET SIZE FOR RESEARCH APPLICATIONS, BY REGION, 2012–2019 ($MILLION)
TABLE 25 TRANSPLANT DIAGNOSTICS MARKET SIZE, BY REGION, 2012–2019 ($MILLION)
TABLE 26 NORTH AMERICA: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION)
TABLE 27 U.S.: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION)
TABLE 28 U.S.: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PRODUCTS AND SERVICES, 2012-2019 ($MILLION)
TABLE 29 U.S.: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2012-2019 ($MILLION)
TABLE 30 U.S.: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2012-2019 ($MILLION)
TABLE 31 CANADA: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION)
TABLE 32 CANADA: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PRODUCTS AND SERVICES, 2012-2019 ($MILLION)
TABLE 33 CANADA: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2012-2019 ($MILLION)
TABLE 34 CANADA: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2012-2019 ($MILLION)
TABLE 35 EUROPEAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION)
TABLE 36 GERMANY: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION)
TABLE 37 GERMANY: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PRODUCTS AND SERVICES, 2012-2019 ($MILLION)
TABLE 38 GERMANY: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2012-2019 ($MILLION)
TABLE 39 GERMANY: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2012-2019 ($MILLION)
TABLE 40 U.K.: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION)
TABLE 41 U.K.: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PRODUCTS AND SERVICES, 2012-2019 ($MILLION)
TABLE 42 U.K.: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2012-2019 ($MILLION)
TABLE 43 U.K.: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2012-2019 ($MILLION)
TABLE 44 FRANCE: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION)
TABLE 45 FRANCE: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PRODUCTS AND SERVICES, 2012-2019 ($MILLION)
TABLE 46 FRANCE: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2012-2019 ($MILLION)
TABLE 47 FRANCE: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2012-2019 ($MILLION)
TABLE 48 REST OF EUROPE: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION)
TABLE 49 REST OF EUROPE: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PRODUCTS AND SERVICES, 2012-2019 ($MILLION)
TABLE 50 REST OF EUROPE: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2012-2019 ($MILLION)
TABLE 51 REST OF EUROPE: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2012-2019 ($MILLION)
TABLE 52 ASIA-PACIFIC: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION)
TABLE 53 JAPAN: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION)
TABLE 54 JAPAN: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PRODUCTS AND SERVICES, 2012-2019 ($MILLION)
TABLE 55 JAPAN: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2012-2019 ($MILLION)
TABLE 56 JAPAN: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2012-2019 ($MILLION)
TABLE 57 CHINA: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION)
TABLE 58 CHINA: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PRODUCTS AND SERVICES, 2012-2019 ($MILLION)
TABLE 59 CHINA: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2012-2019 ($MILLION)
TABLE 60 CHINA: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2012-2019 ($MILLION)
TABLE 61 INDIA: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION)
TABLE 62 INDIA: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PRODUCTS AND SERVICES, 2012-2019 ($MILLION)
TABLE 63 INDIA: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2012-2019 ($MILLION)
TABLE 64 INDIA: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2012-2019 ($MILLION)
TABLE 65 ROAPAC: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION)
TABLE 66 ROAPAC: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PRODUCTS AND SERVICES, 2012-2019 ($MILLION)
TABLE 67 ROAPAC: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2012-2019 ($MILLION)
TABLE 68 ROAPAC: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2012-2019 ($MILLION)
TABLE 69 ROW: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION)
TABLE 70 ROW: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY PRODUCTS AND SERVICES, 2012-2019 ($MILLION)
TABLE 71 ROW: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY END USER, 2012-2019 ($MILLION)
TABLE 72 ROW: TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2012-2019 ($MILLION)
TABLE 73 TOP MERGERS AND ACQUISITIONS, 2012–2014
TABLE 74 TOP AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2012–2014
TABLE 75 TOP NEW PRODUCT LAUNCHES AND PRODUCT ENHANCEMENTS, 2012–2014
TABLE 76 TOP GEOGRAPHICAL EXPANSIONS, 2012–2014
TABLE 77 TOP OTHER DEVELOPMENTS, 2012–2014
LIST OF FIGURES
FIGURE 1 RESEARCH DESIGN
FIGURE 2 BOTTOM-UP APPROACH
FIGURE 3 TOP-DOWN APPROACH
FIGURE 4 DATA TRIANGULATION
FIGURE 5 ASSUMPTIONS OF THE RESEARCH STUDY
FIGURE 6 THE U.S. AND GERMANY TO DRIVE THE REVENUE GROWTH IN TRANSPLANT DIAGNOSTICS MARKET TILL 2019
FIGURE 7 SSP- & SSO-PCR ASSAY TECHNIQUES TO LEAD REVENUE GROWTH IN TRANSPLANT DIAGNOSTIC MARKET DURING THE FORECAST PERIOD
FIGURE 8 TRANSPLANT DIAGNOSTICS MARKET SHARE, BY REGION, 2014
FIGURE 9 THERMO FISHER HOLDS LEADERSHIP POSITION IN THE TRANSPLANT DIAGNOSTIC MARKET (2014)
FIGURE 10 MARKET GROWTH WILL BE DRIVEN BY TECHNOLOGICAL ADVANCEMENTS, RISING GERIATRIC POPULATION
FIGURE 11 MOLECULAR ASSAY TECHNOLOGY TO LEAD REVENUE GROWTH ACROSS KEY REGIONS IN THE TRANSPLANT DIAGNOSTICS MARKET
FIGURE 12 NORTH AMERICA COMMANDED THE LARGEST SHARE OF THE TRANSPLANT DIAGNOSTICS PRODUCTS MARKET IN 2014
FIGURE 13 HOSPITALS AND TRANSPLANT CENTERS TO BE THE FASTEST-GROWING END-USER SEGMENT DURING THE FORECAST PERIOD
FIGURE 14 U.S. AND GERMANY TO LEAD THE MARKET DEMAND FOR TRANSPLANT DIAGNOSTICS APPLICATIONS
FIGURE 15 BY TECHNOLOGY
FIGURE 16 BY PRODUCT
FIGURE 17 BY END USER
FIGURE 18 BY APPLICATION
FIGURE 19 GROWING NUMBER OF TRANSPLANTATION PROCEDURES DRIVING GLOBAL DEMAND FOR TRANSPLANT DIAGNOSTIC PROCEDURES
FIGURE 20 BURGEONING NUMBER OF TRANSPLANTATIONS GIVING A STRONG FILLIP TO U.S. MARKET GROWTH
FIGURE 21 PREVALENCE OF LUNG CANCER WILL BE HIGHEST IN GERIATRIC POPULATION
FIGURE 22 PERCENTAGE CHANGE IN ANNUAL HEALTHCARE EXPENDITURE—DEVELOPED VS. DEVELOPING COUNTRIES (2010-2012)
FIGURE 23 VALUE CHAIN ANALYSIS (2013): MAJOR VALUE IS ADDED DURING R&D PHASE
FIGURE 24 RISING NUMBER OF NEW ENTRANTS IN THE TRANSPLANT DIAGNOSTICS FIELD IS STIMULATING MARKET COMPETITION
FIGURE 25 MOLECULAR ASSAYS ARE THE LARGEST SEGMENT IN THE TRANSPLANT DIAGNOSTIC TECHNOLOGY MARKET
FIGURE 26 PCR TECNIQUES ARE DRIVING THE OVERALL GROWTH OF THE MOLECULAR ASSAYS TECHNOLOGY SEGMENT
FIGURE 27 SEROLOGICAL ASSAYS SEGMENT IS DRIVING THE REVENUE GROWTH OF NON-MOLECULAR TRANSPLANT DIAGNOSTIC TECHNOLOGY MARKET
FIGURE 28 REAGENTS AND CONSUMABLES SEGMENT COMMANDED LARGEST SHARE OF THE GLOBAL TRANSPLANT DIAGNOSTICS MARKET
FIGURE 29 HOSPITALS AND TRANSPLANT CENTERS IS THE FASTEST-GROWING END-USER SEGMENT DURING THE FORECAST PERIOD
FIGURE 30 DIAGNOSTIC APPLICATIONS TO CONTRIBUTE TO THE HIGHEST OVERALL REVENUE GROWTH DURING 2014–2019
FIGURE 31 NORTH AMERICA ACCOUNTED FOR MORE THAN 37% SHARE OF THE GLOBAL TRANSPLANT DIAGNOSTICS MARKET IN 2014
FIGURE 32 EUROPE: A MATURED SEGMENT IN THE TRANSPLANT DIAGNOSTICS MARKET
FIGURE 33 ASIA-PACIFIC REGION IS THE THIRD LARGEST SEGMENT IN TRANSPLANT DIAGNOSTICS MARKET
FIGURE 34 LEADING MARKET PLAYERS ADOPTED STRATEGIC ACQUISITIONS AS THEIR KEY GROWTH STRATEGY DURING 2012–2014
FIGURE 35 GLOBAL TRANSPLANT DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2013
FIGURE 36 GROWING NUMBER OF STRATEGIC ACQUISITIONS IS STIMULATING MARKET COMPETITION
FIGURE 37 GEOGRAPHIC REVENUE MIX OF THE TOP PLAYERS*
FIGURE 38 STRATEGIC BENCHMARKING: LEADING COMPANIES FOCUS ON TECHNOLOGICAL ADVANCEMENTS TO STRENGTHEN THEIR MARKET POSITION
FIGURE 39 STRATEGIC BENCHMARKING: THERMO FISHER SCIENTIFIC AGGRESSIVELY FOCUSES ON THE MARKET IN CHINA TO ADDRESS LOCAL DEMAND
FIGURE 40 THERMO FISHER SCIENTIFIC, INC. : COMPANY SNAPSHOT
FIGURE 41 IMMUCOR, INC.: COMPANY SNAPSHOT
FIGURE 42 QIAGEN N.V. : COMPANY SNAPSHOT
FIGURE 43 BIO-RAD LABORATORIES, INC. : COMPANY SNAPSHOT
FIGURE 44 ABBOTT LABORATORIES, INC.: COMPANY SNAPSHOT
FIGURE 45 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
FIGURE 46 ILLUMINA, INC.: COMPANY SNAPSHOT
|
현재위치 : 
